The WACC of Ultragenyx Pharmaceutical Inc (RARE) is 7.7%.
| Range | Selected | |
| Cost of equity | 8.20% - 12.50% | 10.35% |
| Tax rate | 0.50% - 0.70% | 0.60% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 6.6% - 8.7% | 7.7% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.95 | 1.36 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 8.20% | 12.50% |
| Tax rate | 0.50% | 0.70% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 6.6% | 8.7% |
| Selected WACC | 7.7% | |